Plasma Cell Malignancies

We have just over 4,300 outpatient visits per year. We carry out all kinds of myeloma treatment, including new therapies such as bispecific T-cell stimulants, intensive chemotherapy, and high-dose therapy with autologous stem cell transplantation. This allows us to offer our patients the possibility to participate in several clinical studies, especially at our center for clinical cancer studies.